| Authors: |
Ostrominski JW; Brigham and Women's Hospital Heart and Vascular Center and Harvard Medical School, Boston, Massachusetts, USA; Division of Endocrinology, Diabetes and Hypertension, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA. Electronic address: jostrominski@bwh.harvard.edu., Hirsch JS; Division of Kidney Diseases and Hypertension, Department of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Great Neck, New York, USA., Miao B; Boehringer Ingelheim Pharmaceuticals, Inc, Ridgefield, Connecticut, USA., Clark B; Boehringer Ingelheim Pharmaceuticals, Inc, Ridgefield, Connecticut, USA., Donato BMK; Boehringer Ingelheim Pharmaceuticals, Inc, Ridgefield, Connecticut, USA., Woolley JJ; Medicus Economics, Boston, Massachusetts, USA., Parrinello CM; Pine Mountain Consulting, Redding, Connecticut, USA., O'Connell T; Medicus Economics, Boston, Massachusetts, USA., Vaduganathan M; Brigham and Women's Hospital Heart and Vascular Center and Harvard Medical School, Boston, Massachusetts, USA. Electronic address: mvaduganathan@bwh.harvard.edu. |